C-kit mutations in core binding factor leukemias

2000299 citationsJournal Articlebronze Open Access

Authors

Alessandro Beghini · University of Milan

Paolo Peterlongo · University of Milan

Carla B. Ripamonti · Fondazione Humanitas per la Ricerca

Lidia Larizza · IRCCS Istituto Auxologico Italiano

Roberto Cairoli · University of Milan

Enrica Morra · University of Milan

Cristina Mecucci ·

Abstract

To the editor: C-kit mutations in core binding factor leukemias Positivity for CD117(c-kit) expression is present in 80% of acute myeloblastic leukemia (AML) cases,[1][1] and has been associated with the expression of CD33, a marker of myeloid precursors, and CD13, a myeloid-associated antigen.[2

Topics & Keywords

Acute Myeloid Leukemia Research Chronic Myeloid Leukemia Treatments Protein Degradation and Inhibitors

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Blood

Volume 95, Issue 2, pp. 726-728

DOI: 10.1182/blood.v95.2.726

Field-Weighted Citation Impact: 11.77